Capital World Investors Mesoblast LTD Transaction History

Capital World Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 18, 2020	SELL	$5.74 - $7.42 $2.14 Million - $2.77 Million	-373,077 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.68 - $7.42 $243 - $385	52 Added 0.01%	373,077 $2.58 Million
Q2 2019 Aug 14, 2019	BUY	$4.67 - $5.88 $1,050 - $1,323	225 Added 0.06%	373,025 $1.98 Million
Q1 2019 May 15, 2019	SELL	$4.19 - $5.25 $335,200 - $420,000	-80,000 Reduced 17.67%	372,800 $1.96 Million
Q3 2018 Nov 14, 2018	BUY	$5.75 - $8.16 $2.6 Million - $3.69 Million	452,800 New	452,800 $3.7 Million

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.2B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.